193 related articles for article (PubMed ID: 15671265)
1. Mechanism of protection from light-induced retinal degeneration by the synthetic antioxidant phenyl-N-tert-butylnitrone.
Tomita H; Kotake Y; Anderson RE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):427-34. PubMed ID: 15671265
[TBL] [Abstract][Full Text] [Related]
2. Protein modifications by 4-hydroxynonenal and 4-hydroxyhexenal in light-exposed rat retina.
Tanito M; Elliott MH; Kotake Y; Anderson RE
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3859-68. PubMed ID: 16186375
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of phenyl-N-tert-butylnitrone protects the retina from light damage.
Ranchon I; Chen S; Alvarez K; Anderson RE
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1375-9. PubMed ID: 11328754
[TBL] [Abstract][Full Text] [Related]
4. Delayed loss of cone and remaining rod photoreceptor cells due to impairment of choroidal circulation after acute light exposure in rats.
Tanito M; Kaidzu S; Anderson RE
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1864-72. PubMed ID: 17389522
[TBL] [Abstract][Full Text] [Related]
5. Free radical trap phenyl-N-tert-butylnitrone protects against light damage but does not rescue P23H and S334ter rhodopsin transgenic rats from inherited retinal degeneration.
Ranchon I; LaVail MM; Kotake Y; Anderson RE
J Neurosci; 2003 Jul; 23(14):6050-7. PubMed ID: 12853423
[TBL] [Abstract][Full Text] [Related]
6. Alleviation of constant-light-induced photoreceptor degeneration by adaptation of adult albino rat to bright cyclic light.
Li F; Cao W; Anderson RE
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4968-75. PubMed ID: 14578424
[TBL] [Abstract][Full Text] [Related]
7. Treatment with {alpha}-phenyl-N-tert-butylnitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during alloimmune activation in rat cardiac allografts.
Pieper GM; Nilakantan V; Zhou X; Khanna AK; Johnson CP; Roza AM; Adams MB; Hilton G; Felix CC
J Pharmacol Exp Ther; 2005 Feb; 312(2):774-9. PubMed ID: 15347735
[TBL] [Abstract][Full Text] [Related]
8. Light history and age-related changes in retinal light damage.
Organisciak DT; Darrow RM; Barsalou L; Darrow RA; Kutty RK; Kutty G; Wiggert B
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1107-16. PubMed ID: 9620069
[TBL] [Abstract][Full Text] [Related]
9. Photoreceptor protection against light damage by AAV-mediated overexpression of heme oxygenase-1.
Sun MH; Pang JH; Chen SL; Kuo PC; Chen KJ; Kao LY; Wu JY; Lin KK; Tsao YP
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5699-707. PubMed ID: 18055822
[TBL] [Abstract][Full Text] [Related]
10. Alpha-phenyl-N-tert-butylnitrone (PBN) prevents light-induced degeneration of the retina by inhibiting RPE65 protein isomerohydrolase activity.
Mandal MN; Moiseyev GP; Elliott MH; Kasus-Jacobi A; Li X; Chen H; Zheng L; Nikolaeva O; Floyd RA; Ma JX; Anderson RE
J Biol Chem; 2011 Sep; 286(37):32491-501. PubMed ID: 21785167
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-Induced Leucine Zipper Protects the Retina From Light-Induced Retinal Degeneration by Inducing Bcl-xL in Rats.
Gu R; Tang W; Lei B; Ding X; Jiang C; Xu G
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3656-3668. PubMed ID: 28728173
[TBL] [Abstract][Full Text] [Related]
12. Gene expression in the mouse retina: the effect of damaging light.
Grimm C; Wenzel A; Hafezi F; Remé CE
Mol Vis; 2000 Dec; 6():252-60. PubMed ID: 11134582
[TBL] [Abstract][Full Text] [Related]
13. Delay of photoreceptor cell degeneration in rd mice by systemically administered phenyl-N-tert-butylnitrone.
Kim JH; Kim JH; Yu YS; Jeong SM; Kim KW
Korean J Ophthalmol; 2005 Dec; 19(4):288-92. PubMed ID: 16491819
[TBL] [Abstract][Full Text] [Related]
14. Clinical light exposure, photoreceptor degeneration, and AP-1 activation: a cell death or cell survival signal in the rhodopsin mutant retina?
Gu D; Beltran WA; Li Z; Acland GM; Aguirre GD
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4907-18. PubMed ID: 17962438
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration.
Wong P; Markey M; Rapp CM; Darrow RM; Ziesel A; Organisciak DT
Mol Vis; 2017; 23():718-739. PubMed ID: 29062223
[TBL] [Abstract][Full Text] [Related]
16. Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina.
Maccarone R; Di Marco S; Bisti S
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1254-61. PubMed ID: 18326756
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection in the juvenile rat model of light-induced retinopathy: evidence suggesting a role for FGF-2 and CNTF.
Joly S; Pernet V; Chemtob S; Di Polo A; Lachapelle P
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2311-20. PubMed ID: 17460296
[TBL] [Abstract][Full Text] [Related]
18. Steroids do not prevent photoreceptor degeneration in the light-exposed T4R rhodopsin mutant dog retina irrespective of AP-1 inhibition.
Gu D; Beltran WA; Pearce-Kelling S; Li Z; Acland GM; Aguirre GD
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3482-94. PubMed ID: 19234347
[TBL] [Abstract][Full Text] [Related]
19. Time course of neurotrophic factor upregulation and retinal protection against light-induced damage after optic nerve section.
Valter K; Bisti S; Gargini C; Di Loreto S; Maccarone R; Cervetto L; Stone J
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1748-54. PubMed ID: 15851578
[TBL] [Abstract][Full Text] [Related]
20. Analysis of complement expression in light-induced retinal degeneration: synthesis and deposition of C3 by microglia/macrophages is associated with focal photoreceptor degeneration.
Rutar M; Natoli R; Kozulin P; Valter K; Gatenby P; Provis JM
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5347-58. PubMed ID: 21571681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
